Patents by Inventor Thomas Von Hahn

Thomas Von Hahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HCV coreceptor and methods of use thereof
    Patent number: 8703149
    Abstract: The invention relates to the discovery that the Claudin-1 protein functions as a co-receptor for entry of HCV into cells. Methods of inhibiting, preventing or mitigating HCV infections by inhibiting HCV interactions with Claudin-1 are provided. Methods of identifying agents or compounds that interfere with HCV interactions with Claudin-1 are also provided. Finally, useful kits, cell culture compositions, agents, and compounds related to the inhibition of HCV interactions with Claudin-1 are also disclosed.
    Type: Grant
    Filed: August 23, 2011
    Date of Patent: April 22, 2014
    Assignee: The Rockefeller University
    Inventors: Charles Rice, Matthew J. Evans, Thomas Von Hahn
  • HCV Coreceptor and Methods of Use Thereof
    Publication number: 20120054879
    Abstract: The invention relates to the discovery that the Claudin-1 protein functions as a co-receptor for entry of HCV into cells. Methods of inhibiting, preventing or mitigating HCV infections by inhibiting HCV interactions with Claudin-1 are provided. Methods of identifying agents or compounds that interfere with HCV interactions with Claudin-1 are also provided. Finally, useful kits, cell culture compositions, agents, and compounds related to the inhibition of HCV interactions with Claudin-1 are also disclosed.
    Type: Application
    Filed: August 23, 2011
    Publication date: March 1, 2012
    Applicant: THE ROCKEFELLER UNIVERSITY
    Inventors: Charles Rice, Matthew J. Evans, Thomas Von Hahn
  • HCV coreceptor and methods of use thereof
    Patent number: 8021835
    Abstract: The invention relates to the discovery that the Claudin-1 protein functions as a co-receptor for entry of HCV into cells. Methods of inhibiting, preventing or mitigating HCV infections by inhibiting HCV interactions with Claudin-1 are provided. Methods of identifying agents or compounds that interfere with HCV interactions with Claudin-1 are also provided. Finally, useful kits, cell culture compositions, agents, and compounds related to the inhibition of HCV interactions with Claudin-1 are also disclosed.
    Type: Grant
    Filed: May 4, 2007
    Date of Patent: September 20, 2011
    Assignee: The Rockefeller University
    Inventors: Charles Rice, Matthew J. Evans, Thomas Von Hahn
  • HCV CORECEPTOR AND METHODS OF USE THEREOF
    Publication number: 20090098123
    Abstract: The invention relates to the discovery that the Claudin-1 protein functions as a co-receptor for entry of HCV into cells. Methods of inhibiting, preventing or mitigating HCV infections by inhibiting HCV interactions with Claudin-1 are provided. Methods of identifying agents or compounds that interfere with HCV interactions with Claudin-1 are also provided. Finally, useful kits, cell culture compositions, agents, and compounds related to the inhibition of HCV interactions with Claudin-1 are also disclosed.
    Type: Application
    Filed: May 4, 2007
    Publication date: April 16, 2009
    Applicant: The Rockefeller University
    Inventors: Charles Rice, Matthew J. Evans, Thomas Von Hahn